|
Published by: Millennium Research
Published: Jun. 1, 2005
Table of Contents
- METHODOLOGY
- 1.0 GLOBAL SOFT TISSUE REPAIR MARKET
- 1.1 US Soft Tissue Repair Market
- 1.2 European Soft Tissue Repair Market
- 1.3 Japanese Soft Tissue Repair Market
- 1.4 Competitive Analysis
- 2.0 C.R. BARD
- 2.1 Company Overview
- 2.2 Recent Events/Strategy
- 2.3 Products Offered
- 2.4 Global Sales Performance
- 2.4.1 US
- 2.4.2 Europe
- 2.4.3 Japan
- 2.5 S.W.O.T. Analysis
- 2.5.1 Strengths
- 2.5.2 Weaknesses
- 2.5.3 Opportunities
- 2.5.4 Threats
- 3.0 GYNECARE
- 3.1 Company Overview
- 3.2 Recent Events/Strategy
- 3.3 Products Offered
- 3.4 Global Sales Performance
- 3.4.1 US
- 3.4.2 Europe
- 3.4.3 Japan
- 3.5 S.W.O.T. Analysis
- 3.5.1 Strengths
- 3.5.2 Weaknesses
- 3.5.3 Opportunities
- 3.5.4 Threats
- 4.0 W.L. GORE
- 4.1 Company Overview
- 4.2 Recent Events/Strategy
- 4.3 Products Offered
- 4.4 Global Sales Performance
- 4.4.1 US
- 4.4.2 Europe
- 4.4.3 Japan
- 4.5 S.W.O.T. Analysis
- 4.5.1 Strengths
- 4.5.2 Weaknesses
- 4.5.3 Opportunities
- 4.5.4 Threats
- 5.0 ETHICON
- 5.1 Company Overview
- 5.2 Recent Events/Strategy
- 5.3 Products Offered
- 5.4 Global Sales Performance
- 5.4.1 US
- 5.4.2 Europe
- 5.4.3 Japan
- 5.5 S.W.O.T. Analysis
- 5.5.1 Strengths
- 5.5.2 Weaknesses
- 5.5.3 Opportunities
- 5.5.4 Threats
- 6.0 AMERICAN MEDICAL SYSTEMS
- 6.1 Company Overview
- 6.2 Recent Events/Strategy
- 6.3 Products Offered
- 6.4 Global Sales Performance
- 6.4.1 US
- 6.4.2 Europe
- 6.4.3 Japan
- 6.5 S.W.O.T. Analysis
- 6.5.1 Strengths
- 6.5.2 Weaknesses
- 6.5.3 Opportunities
- 6.5.4 Threats
- 7.0 SYNOVIS LIFE TECHNOLOGIES
- 7.1 Company Overview
- 7.2 Recent Events/Strategy
- 7.3 Products Offered
- 7.4 Global Sales Performance
- 7.4.1 US
- 7.4.2 Europe
- 7.5 S.W.O.T. Analysis
- 7.5.1 Strengths
- 7.5.2 Weaknesses
- 7.5.3 Opportunities
- 7.5.4 Threats
- 8.0 BOSTON SCIENTIFIC
- 8.1 Company Overview
- 8.2 Recent Events/Strategy
- 8.3 Products Offered
- 8.4 Global Sales Performance
- 8.5 S.W.O.T. Analysis
- 8.5.1 Strengths
- 8.5.2 Weaknesses
- 8.5.3 Opportunities
- 8.5.4 Threats
- 9.0 SOFRADIM
- 9.1 Company Overview
- 9.2 Recent Events/Strategy
- 9.3 Products Offered
- 9.4 Global Sales Performance
- 9.4.1 US
- 9.4.2 Europe
- 9.5 S.W.O.T. Analysis
- 9.5.1 Strengths
- 9.5.2 Weaknesses
- 9.5.3 Opportunities
- 9.5.4 Threats
- 10.0 MENTOR
- 10.1 Company Overview
- 10.2 Recent Events/Strategy
- 10.3 Products Offered
- 10.4 Global Sales Performance
- 10.4.1 US
- 10.4.2 Europe
- 10.5 S.W.O.T. Analysis
- 10.5.1 Strengths
- 10.5.2 Weaknesses
- 10.5.3 Opportunities
- 10.5.4 Threats
- 11.0 COOK..
- 11.1 Company Overview
- 11.2 Recent Events/Strategy
- 11.3 Products Offered
- 11.4 Global Sales Performance
- 11.4.1 US
- 11.4.2 Europe
- 11.4.3 Japan
- 11.5 S.W.O.T. Analysis
- 11.5.1 Strengths
- 11.5.2 Weaknesses
- 11.5.3 Opportunities
- 11.5.4 Threats
- APPENDIX A: MRG ACRONYMS AND INITIALISMS
- List of Exhibits
- Chapter 1: Global Soft Tissue Repair Market
- Exhibit 1-1: Soft Tissue Repair Market, by Region, Global (US$), 2003-2009 (Tabular Format)
- Exhibit 1-2: Soft Tissue Repair Market, by Region, Global (US$), 2003-2009 (Graphical Format)
- Exhibit 1-3: Soft Tissue Repair Market, by Type, US, 2003-2009 (Tabular Format)
- Exhibit 1-4: Soft Tissue Repair Market, by Type, US, 2003-2009 (Graphical Format)
- Exhibit 1-5: Soft Tissue Repair Market, by Type and Country, Europe, 2003-2009
- Exhibit 1-6: Soft Tissue Repair Market, by Type, Europe, 2003-2009
- Exhibit 1-7: Soft Tissue Repair Market, by Type, Japan, 2003-2009 (Tabular Format)
- Exhibit 1-8: Soft Tissue Repair Market, by Type, Japan, 2003-2009 (Graphical Format)
- Exhibit 1-9: Leading Competitors in the Soft Tissue Repair Market, by Region, Global, 2004
- Chapter 2: C.R. Bard
- Exhibit 2-1: C.R. Bard’s Hernia Repair Product Offering
- Exhibit 2-2: C.R. Bard’s Other Soft Tissue Product Offering
- Exhibit 2-3: C.R. Bard’s Soft Tissue Repair Sales, by Region and Type, Global, 2004
- Exhibit 2-4: C.R. Bard’s Soft Tissue Repair Sales, by Region, Global, 2004
- Exhibit 2-5: C.R. Bard’s Soft Tissue Repair Sales, by Country, Europe, 2004 (Tabular Format)
- Exhibit 2-6: C.R. Bard’s Soft Tissue Repair Sales, by Country, Europe, 2004 ((Graphical Format)
- Exhibit 2-7: S.W.O.T. Analysis, C.R. Bard
- Chapter 3: Gynecare
- Exhibit 3-1: Gynecare’s Product Offering
- Exhibit 3-2: Gynecare’s Soft Tissue Repair Sales, by Region and Type, Global, 2004
- Exhibit 3-3: Gynecare’s Soft Tissue Repair Sales, by Region, Global, 2004
- Exhibit 3-4: Gynecare’s Soft Tissue Repair Sales, by Country, Europe, 2004 (Tabular Format)
- Exhibit 3-5: Gynecare’s Soft Tissue Repair Sales, by Country, Europe, 2004 (Graphical Format)
- Exhibit 3-6: S.W.O.T. Analysis, Gynecare
- Chapter 4: W.L. Gore
- Exhibit 4-1: W.L. Gore’s Product Offering
- Exhibit 4-2: W.L. Gore’s Soft Tissue Repair Sales, by Region and Type, Global, 2004
- Exhibit 4-3: W.L. Gore’s Soft Tissue Repair Sales, by Region, Global, 2004
- Exhibit 4-4: W.L. Gore’s Soft Tissue Repair Sales, by Country, Europe, 2004 (Tabular Format)
- Exhibit 4-5: W.L. Gore’s Soft Tissue Repair Sales, by Country, Europe, 2004 (Graphical Format)
- Exhibit 4-6: S.W.O.T. Analysis, W.L. Gore
- Chapter 5: Ethicon
- Exhibit 5-1: Ethicon’s Product Offering
- Exhibit 5-2: Ethicon’s Soft Tissue Repair Sales, by Region and Type, Global, 2004
- Exhibit 5-3: Ethicon’s Soft Tissue Repair Sales, by Region, Global, 2004
- Exhibit 5-4: Ethicon’s Soft Tissue Repair Sales, by Country, Europe, 2004 (Tabular Format)
- Exhibit 5-5: Ethicon’s Soft Tissue Repair Sales, by Country, Europe, 2004 (Graphical Format)
- Exhibit 5-6: S.W.O.T. Analysis, Ethicon
- Chapter 6: American Medical Systems
- Exhibit 6-1: American Medical Systems’ Product Offering
- Exhibit 6-2: American Medical Systems’ Soft Tissue Repair Sales, by Region and Type, Global, 2004
- Exhibit 6-3: American Medical Systems’ Soft Tissue Repair Sales, by Region, Global, 2004
- Exhibit 6-4: American Medical Systems’ Soft Tissue Repair Sales, by Country, Europe, 2004 (Tabular Format)
- Exhibit 6-5: American Medical Systems’ Soft Tissue Repair Sales, by Country, Europe, 2004 (Graphical Format)
- Exhibit 6-6: S.W.O.T. Analysis, American Medical Systems
- Chapter 7: Synovis Life Technologies
- Exhibit 7-1: Synovis Life Technologies’ Product Offering
- Exhibit 7-2: Synovis Life Technologies’ Soft Tissue Repair Sales, by Region and Type, Global, 2004
- Exhibit 7-3: S.W.O.T. Analysis, Synovis Life Technologies
- Chapter 8: Boston Scientific
- Exhibit 8-1: Boston Scientific’s Product Offering
- Exhibit 8-2: Boston Scientific’s Soft Tissue Repair Sales, by Region and Type, Global, 2004
- Exhibit 8-3: S.W.O.T. Analysis, Boston Scientific
- Chapter 9: Sofradim
- Exhibit 9-1: Sofradim’s Product Offering
- Exhibit 9-2: Sofradim’s Soft Tissue Repair Sales, by Region and Type, Global, 2004
- Exhibit 9-3: Sofradim’s Soft Tissue Repair Sales, by Region, Global, 2004
- Exhibit 9-4: Sofradim’s Soft Tissue Repair Sales, by Country, Europe, 2004 (Tabular Format)
- Exhibit 9-5: Sofradim’s Soft Tissue Repair Sales, by Country, Europe, 2004 (Graphical Format)
- Exhibit 9-6: S.W.O.T. Analysis, Sofradim
- Chapter 10: Mentor
- Exhibit 10-1: Mentor’s Product Offering
- Exhibit 10-2: Mentor’s Soft Tissue Repair Sales, by Region and Type, Global, 2004
- Exhibit 10-3: S.W.O.T. Analysis, Mentor
- Chapter 11: Cook
- Exhibit 11-1: Cook’s Product Offering
- Exhibit 11-2: Cook’s Soft Tissue Repair Sales, by Region and Type, Global, 2004
- Exhibit 11-3: S.W.O.T. Analysis, Cook
AbstractGrowth in the market will be spurred primarily by the conversion from traditional autograft and suturing techniques to the use of commercial biomaterials.
In addition, an aging population, increasing number of competitors developing tissue-engineering technologies, and the desire for minimally invasive therapies by both physicians and patients will drive demand for soft tissue repair products in the following market segments:
- hernia repair
- vaginal slings
- dural repair
- pelvic floor reconstruction
- cardiovascular (CV) patches
- staple line reinforcement (SLR) material
- rotator cuff repair
Get Full Details About This Report >>
|
|
US: 800.298.5699
Int'l: +1.240.747.3093
|
|
|